Prostaglandin E2 binds to and activates four different receptor subtypes, EP1, EP2, EP3 and EP4 (Bos et al, 2004), suggesting that one (or more) EP receptor is involved in inducing FasL expression in colon cancer cells. Here, PTGER3 is linked to colonic neoplasm.